SCHEMBL7939470

SCHEMBL7939470

CCCOc1cc(C(=O)O)c2ccccc2n1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.65
KDM4E B2RXH2 8/20 0.59
HTR3E A5X5Y0 5/20 0.58
HTR3B O95264 5/20 0.58
HTR3A P46098 5/20 0.58
HTR3D Q70Z44 5/20 0.58
HTR3C Q8WXA8 5/20 0.58
LMNA P02545 5/20 0.57
SMN1; SMN2 Q16637 5/20 0.57
ALDH1A1 P00352 4/20 0.57
HPGD P15428 2/20 0.57
GAA P10253 2/20 0.57
ABCB11 O95342 1/20 0.57
CYP1A2 P05177 1/20 0.57
CYP2D6 P10635 1/20 0.57
SCN1A P35498 1/20 0.57
OPRK1 P41145 1/20 0.57
KCNH2 Q12809 1/20 0.57
CACNA1C Q13936 1/20 0.57
SCN5A Q14524 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6250517 0.93 KDM4E (0.65) PDE10AKDM4EHTR3EHTR3BHTR3A
SCHEMBL31673005 0.93 KDM4E (0.65) PDE10AKDM4EHTR3EHTR3BHTR3A
SCHEMBL9198147 0.92 HTR3E (0.61) PDE10AKDM4EHTR3EHTR3BHTR3A
SCHEMBL29176330 0.91 HTR3E (0.61) PDE10AKDM4EHTR3EHTR3BHTR3A
SCHEMBL9198080 0.91 HTR3E (0.61) PDE10AKDM4EHTR3EHTR3BHTR3A
SCHEMBL9203821 0.88 KDM4E (0.64) PDE10AKDM4EHTR3EHTR3BHTR3A
SCHEMBL13490841 0.86 KDM4E (0.55) PDE10AKDM4EHTR3EHTR3BHTR3A
SCHEMBL28337139 0.84 KDM4E (0.71) PDE10AKDM4EHTR3EHTR3BHTR3A
SCHEMBL28378761 0.82 KDM4E (0.62) PDE10AKDM4EHTR3EHTR3BHTR3A
SCHEMBL89106 0.82 HTR3E (0.48) PDE10AKDM4EHTR3EHTR3BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001095903-A1 5-HT3 RECEPTOR ANTAGONISTS FOR TREATMENT OF DISORDERS INVOLVING AIRWAY CONSTRICTION RESPIRATORIUS AB (SE) 2001-12-20 WO disclosed
EP-0564650-B1 QUINOLINE DERIVATIVE KYOWA HAKKO KOGYO KK (JP) 1995-09-20 EP disclosed
US-5319085-A Antiemetic agents; anticarcinogenic agent-induced vomiting; antianxiolytic agents; psychological disorders KYOWA HAKKO KOGYO CO., LTD. (JP) 1994-06-07 US disclosed
EP-0564650-A1 QUINOLINE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 1993-10-13 EP disclosed